SYNEIKA applications

There is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain.

Repetitive TMS has beneficial effects on motor recovery that can be translated to clinically meaningful improvement in disability in patients with post-stroke hemiparesis.

Transcranial magnetic stimulation is effective in treating major depression with minimal side effects reported. It offers clinicians a novel alternative for the treatment of this disorder.